Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs

This publication has 28 references indexed in Scilit:

• Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion
  European Journal of Pharmacology, 1989
• Antiarrhythmic effect of a specific PAF antagonist (BN 52021) on ischemia-reperfusion in the dog *1JM. Guillon, P. Thievant, M. Koltain, E. Pirotzky, P. Braquet. Institute Henri Beaufour, 1, Avenue des Tropiques, Les Ulis, France
  Journal of Molecular and Cellular Cardiology, 1989
• Is there a case for PAF antagonists in the treatment of ischemie states?
  Trends in Pharmacological Sciences, 1989
• Myocardial reperfusion: a double-edged sword?
  Journal of Clinical Investigation, 1985
• Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether
  Immunopharmacology, 1985
• CV-3988 - A specific antagonist of platelet activating factor (PAF)
  Life Sciences, 1983
• Cardioprotective Effects of Ibuprofen in Experimental Regional and Global Myocardial Ischemia
  Journal of Cardiovascular Pharmacology, 1982
• Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog
  The American Journal of Cardiology, 1980
• The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation.
  Circulation, 1979
• Technique for precise, graded arterial stenosis and occlusion
  Basic Research in Cardiology, 1977